Table 1. Baseline characteristics of acute ischemic stroke patients and normal cases.
Characteristics | All(n = 240) | Normal cases (n = 100) | pa |
Male sex (%) | 166(69.2) | 70(70.0) | NS |
Age (years), median(IQR) | 67(53–76) | 66(52–77) | NS |
Stroke severity, median NIHSS score (IQR) | 8(5–11) | – | – |
Infarct volume(mL, IQR; n = 183) | 10(7–22) | – | – |
Vascular risk factors no. (%) | |||
Diabetes mellitus | 54(22.5) | – | – |
Hypertension | 172(71.7) | ||
Coronary heart disease | 61(25.4) | – | – |
Atrial fibrillation | 55(22.9) | ||
Hypercholesterolemia | 66(27.5) | – | – |
Family history for stroke | 52(21.7) | – | – |
Smoking habit | 49(20.4) | – | – |
Clinical findings median(IQR) | |||
Temperature (°C) | 37.0(36.4–37.4) | 36.5(36.3–36.8) | <0.01 |
BMI (kg m−2) | 24.8(23.2–27.4) | 24.7(23.3–27.2) | NS |
Heart rate (beats min−1) | 82(72–91) | 79(67–87) | NS |
Systolic blood pressure(mmHg) | 158(144–175) | 127(112–134) | <0.001 |
Diastolic blood pressure(mmHg) | 94(80–99) | 80(75–86) | <0.01 |
Laboratory findings (median, IQR) | |||
Glucose(mmol L−1) | 5.99(5.52–6.68) | 5.45(4.76–5.93) | <0.001 |
C-reactive protein (mgL−1) | 5.5(3.3–9.3) | 3.2(2.5–6.6) | <0.01 |
Leucocyte count (×103 m L−1) | 8.2(6.3–9.4) | 8.1(6.2–9.3) | NS |
PT(second) | 12.3(11.2–1.3.1) | 11.1(10.6–11.6) | <0.01 |
APTT(second) | 28.3(25.9–30.2) | 26.9(24.5–28.6) | <0.01 |
TT(second) | 18.3(17.7–19.1) | 18.1(17.6–18.9) | NS |
FBG(g L−1) | 3.54(3.05–3.99) | 2.93(2.34–3.66) | <0.01 |
D-dimer(mg L−1) | 0.88(0.28–2.11) | 0.31(0.17–0.74) | <0.001 |
Stroke syndrome no. (%) | |||
TACS | 31(12.9) | – | – |
PACS | 95(39.6) | – | – |
LACS | 55(22.9) | ||
POCS | 59(24.6) | – | – |
Stroke etiology no. (%) | |||
Small-vessel occlusive | 47(19.6) | – | – |
Large-vessel occlusive | 49(20.4) | ||
Cardioembolic | 98(40.8) | – | – |
Other | 22(9.2) | – | – |
Unknown | 24(10.0) | – | – |
IQR, interquartile range; TACS, total anterior circulation syndrome; LACS, lacunar syndrome; PACS, partial anterior circulation syndrome; POCS, posterior circulation syndrome; NIHSS, National Institutes of Health Stroke Scale; CRP, C-reactive protein; PT, prothrombin time; APTT, activated partial thromboplastin time; TT, thrombin time; FBG, fibrinogen.
a p value was assessed using Mann-Whitney U test or χ2 test.